Continuous Low-pH Virus Inactivation: Challenges and Practical Solutions

Genetic Engineering & Biotechnology NewsVol. 38, No. 15 Continuous Low-pH Virus Inactivation: Challenges and Practical SolutionsPall Biotech Describes an Automated and Semicontinous Multivessel SystemMark Schofield and David JohnsonMark SchofieldMark Schofield, Ph.D. (E-mail Address: mark_schofield@pall.com), is senior research and development manager and David Johnson is senior global product manager at Pall Biotech. Website: biotech.pall.com.Search for more papers by this author and David JohnsonMark Schofield, Ph.D. (E-mail Address: mark_schofield@pall.com), is senior research and development manager and David Johnson is senior global product manager at Pall Biotech. Website: biotech.pall.com.Search for more papers by this authorPublished Online:1 Sep 2018https://doi.org/10.1089/gen.38.15.12AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 38Issue 15Sep 2018 InformationCopyright © GEN PublishingTo cite this article:Mark Schofield and David Johnson.Continuous Low-pH Virus Inactivation: Challenges and Practical Solutions.Genetic Engineering & Biotechnology News.Sep 2018.S13-S15.http://doi.org/10.1089/gen.38.15.12Published in Volume: 38 Issue 15: September 1, 2018PDF download